Hydroxocobalamin and Ulcer - duodenal or gastric - a phase IV clinical study of FDA data

Summary:

Ulcer - duodenal or gastric is found among people who take Hydroxocobalamin, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Hydroxocobalamin and have Ulcer - duodenal or gastric. It is created by eHealthMe based on reports of 3,396 people who have side effects when taking Hydroxocobalamin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 28, 2022

3,396 people reported to have side effects when taking Hydroxocobalamin.
Among them, 13 people (0.38%) have Ulcer - duodenal or gastric.


What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 3,424 Hydroxocobalamin users for its effectiveness, alternative drugs and more.

What is Ulcer - duodenal or gastric?

Ulcer - duodenal or gastric is found to be associated with 3,325 drugs and 3,125 conditions by eHealthMe.

Number of Hydroxocobalamin and Ulcer - duodenal or gastric reports submitted per year:

Could Hydroxocobalamin cause Ulcer - duodenal or gastric?

Time on Hydroxocobalamin when people have Ulcer - duodenal or gastric *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ulcer - duodenal or gastric when taking Hydroxocobalamin *:

  • female: 46.15 %
  • male: 53.85 %

Age of people who have Ulcer - duodenal or gastric when taking Hydroxocobalamin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 11.11 %
  • 60+: 88.89 %

Common drugs people take besides Hydroxocobalamin *:

  1. Sitagliptin: 4 people, 30.77%
  2. Metformin: 4 people, 30.77%
  3. Lyrica: 2 people, 15.38%
  4. Motrin: 2 people, 15.38%
  5. Estrace: 2 people, 15.38%
  6. Kapidex: 2 people, 15.38%
  7. Klonopin: 2 people, 15.38%
  8. Lidoderm: 2 people, 15.38%
  9. Xyrem: 2 people, 15.38%
  10. Miralax: 2 people, 15.38%

Common side effects people have besides Ulcer - duodenal or gastric *:

  1. Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 23.08%
  2. Fall: 3 people, 23.08%
  3. Muscle Spasms (muscle contraction): 2 people, 15.38%
  4. Anaemia (lack of blood): 2 people, 15.38%
  5. Back Disorder: 2 people, 15.38%
  6. Gait Disturbance: 2 people, 15.38%
  7. Nausea And Vomiting: 2 people, 15.38%
  8. Road Traffic Accident: 2 people, 15.38%
  9. Kidney Stones: 2 people, 15.38%
  10. Pain: 2 people, 15.38%

Common conditions people have *:

  1. Penile Ulceration: 3 people, 23.08%
  2. Sleep Disorder: 2 people, 15.38%
  3. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 15.38%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.69%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
  6. Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 1 person, 7.69%
  7. Nausea (feeling of having an urge to vomit): 1 person, 7.69%
  8. Dumping Syndrome (a condition that can develop after surgery to remove all or part of your stomach or after surgery to bypass your stomach to help you lose weight): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and have Ulcer - duodenal or gastric?

Check whether Ulcer - duodenal or gastric is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Ulcer - duodenal or gastric and when was it recovered:

Expand to all the drugs that have ingredients of hydroxocobalamin:

Alternative drugs to, pros and cons of Hydroxocobalamin:

Common Hydroxocobalamin side effects:

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ulcer - duodenal or gastric treatments and more:

COVID vaccines that are related to Ulcer - duodenal or gastric:

Common drugs associated with Ulcer - duodenal or gastric:

All the drugs that are associated with Ulcer - duodenal or gastric:

Common conditions associated with Ulcer - duodenal or gastric:

All the conditions that are associated with Ulcer - duodenal or gastric:

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: